loading page

Risk assessment and prognostic aspect of coagulopathy in Coronavirus Disease 2019 (COVID-19)
  • MUJIBUR RAHMAN,
  • Nadira Naznin Rakhi
MUJIBUR RAHMAN
BSMRSTU
Author Profile
Nadira Naznin Rakhi
Bangabandhu Sheikh Mujibur Rahman Science and Technology University
Author Profile

Abstract

Since December 2019, the rapid spread of SARS CoV-2 across the border, shuffled into a world pandemic situation with an alarming rate of morbidity and mortality. Concerns are mounting as the reports indicate tangled circumstances among the COVID-19 patients due to blood coagulopathy followed by organ dysfunction. COVID-19 induced an alteration in coagulation function increase the risk of pulmonary embolism and deep vein thrombosis associated with poor prognosis as well as high mortality. An elevated level D-dimer and other fibrin degrading protein are documented among the patients with COVID-19; especially in severe cases. Differences in coagulopathy among severe and non-severe cases, required prompt attention to adopt a more effective management strategy.